Abstract. Regulatory T cells (Tregs) serve an important role in the pathogenesis of rheumatoid arthritis (RA) by regulating autoimmunity and inflammation. Humans and mice contain inducible T-cell costimulator-positive (ICOS +
Introduction
Rheumatoid arthritis (RA) is a systemic, chronic, inflammatory autoimmune disease that affects joints and other tissues, including the skin and kidneys (1) . RA affects a large number of individuals worldwide, with nearly three times as many females as men being diagnosed with RA (2) . Studies have suggested that the pathogenesis of RA is triggered by failure in the maintenance of peripheral tolerance to self-antigens, which leads to the activation and expansion of autoreactive T and B cells (3, 4) . These pathogenic T cells and autoantibodies in turn cause joint inflammation that eventually leads to irreversible articular cartilage damage as well as the breakdown of osseous tissue (3, 4) . Various proinflammatory cytokines serve important roles in RA development (4) . Patients with RA exhibit increased numbers of interleukin (IL)-17-producing T helper (h)17 cells in the peripheral blood in comparison with healthy subjects (5, 6) . Additionally, IL-17 was elevated in the synovial fluid of patients with RA and was involved in the pathogenesis of RA (7, 8) . Regulatory T cells (Tregs) were revealed to be crucial for peripheral self-tolerance, as they actively suppress auto-reactive lymphocytes as well as other immune cells and express suppressive cytokines, including IL-10 and transforming growth factor (TGF)-β (9) . It has been reported that Tregs serve an important role in the pathogenesis of RA by regulating autoimmunity and inflammation (10, 11) . Inducible T-cell costimulator (ICOS) is a co-receptor belonging to the cluster of differentiation (CD)28 immunoglobulin (Ig) super family that provide co-stimulatory signals to T cells during antigen-mediated activation (12) .
Reports on murine models for autoimmune diabetes and allergic asthma have described the important roles of ICOS in the generation, maintenance and suppressive functions of Tregs (13, 14) . Notably, ICOS + Tregs exhibited a stronger suppressive activity compared with ICOS -Tregs (15 
Patients and methods
Patients and healthy controls. The current study, which took place at the Department of Rheumatology of Nanfang Hospital, Southern Medical University (Guangzhou, China) from January 2015 to January 2016, examined 33 Chinese patients diagnosed with RA according to the American College of Rheumatology (ACR) criteria (22) . These patients included 31 females and 2 males (age, 49.76±1.73 years). Information concerning the patient's medical history, number of classification criteria fulfilled and laboratory findings were obtained at the time of the clinic visit. Whole blood samples were collected and disease activity was measured using the 28-joint disease activity index (DAS28) (23) . Based on the DAS28, 10 patients possessed iRA (DAS28 score ≤3.3) and 23 possessed aRA (DAS28 score >3.3) during the study. Additionally, 17 healthy subjects were recruited to serve as the normal control (NC) group, the details of which are presented in Table I . All participants provided written consent during their enrollment. The Ethics Committee of Nanfang Hospital approved the current study. Peripheral blood mononuclear cells culture and cytokine analysis. Ficoll density gradient centrifugation (400 x g, 30 min, 21˚C) was used to isolate fresh peripheral mononuclear blood cells (PBMCs) from 5 ml heparin-treated venous blood samples. PBMCs were cultured for 6 days in 12-well culture plates pre-coated with 1 µg/ml purified NA/LE Mouse Anti-Human CD3 (cat. no. 555336; BD Pharmingen; BD Biosciences) with the addition of 300 U/ml recombinant human IL-2 (cat. no. 200-02; Perprotech, Inc., London, UK) for T-cell receptor (TCR) stimulation. Aliquots of PBMCs (1x10 6 ) in 2 ml RPMI 1640 (cat. no. 72400047; Gbico; Thermo Fisher Scientific, Inc.) were supplemented with 10% heat-inactivated fetal bovine serum (Gbico; Thermo Fisher Scientific, Inc.), glutamine (2 mM), penicillin (200 U/ml) and streptomycin (100 µg/ml). Cells were either stained and analysis or treated with PMA and ionomycin in the presence of BFA for 5 h prior to harvesting, performing intracellular cytokine staining and conducting fluorescence-activated cell sorting analysis.
Statistical analysis. All statistical analyses were performed using Prism v5.0 GraphPad software (GraphPad Software, Inc., La Jolla, CA, USA). Quantitative data were expressed as mean ± standard error of the mean. One-Way analysis of variance followed by a Kruskal-Wallis H test was performed to compare three groups. Two-group comparisons were examined by a Mann-Whitney U test. Spearman's correlation was used to assess correlations. P<0.05 indicated that the difference between groups was statistically significant.
Results

ICOS
+ Tregs frequencies are higher in patients with RA but negatively correlate with disease activity. Tregs are essential for the maintenance of peripheral tolerance, for preventing autoimmunity and for limiting chronic inflammatory diseases (24) . Although it has been reported that the number of Tregs are decreased in patients with RA (3) and ICOS + Tregs may be involved in the pathogenesis of numerous tumors and autoimmune diseases (9) , it is unknown whether or not ICOS + Tregs are associated with RA. To address this issue, the percentages of ICOS + Tregs identified in a cohort of Chinese patients with RA and NCs were evaluated. ICOS + Tregs percentages were significantly increased in patients with RA compared with the NCs (6.46±0.56% vs. 2.15±0.20%; P<0.0001; Fig. 1A and B) . By contrast, the percentages of ICOS -Tregs in patients with RA were considerably decreased (34.77±2.10% vs. 58.08±2.40%; P<0.0001; Fig. 1C ). Patients with RA were further divided into aRA and iRA groups according to the DAS28 scores. As indicated in Fig. 1D , the percentages of ICOS + Tregs were significantly increased in the aRA group (4.60±0.23%; P<0.001) and the iRA group (10.74±0.73%; P<0.001) compared with the NC group (2.15±0.20%). Additionally, the iRA group exhibited twice the number of ICOS + Tregs as the aRA group (P<0.0001). Notably, DAS28 scores and ICOS + Tregs percentages were negatively correlated in patients with RA (r=−0.681; P<0.001; Fig. 1E ). Thus, ICOS + Tregs were elevated in patients with RA; however, the magnitude of increase was negatively correlated with disease activity in all patients.
+ Tregs/Th17 ratios are disturbed in patients with RA. Th17 cells serve important roles in autoimmune inflammation (25) . Consistent with previous studies (5, 6) , it was revealed that Th17 cell percentages in the patients with RA were significantly larger compared with the NCs (6.04±0.84% vs. 0.43±0.05%; P<0.0001; Fig. 2A) . Additionally, Th17 percentages were ~6.5 times higher in patients with aRA (8.09±0.91%) compared with that in patients with iRA (1.34±0.18%; P<0.0001) and ~7.5 times higher than in the NCs (0.43±0.05%; P<0.0001; Fig. 2B ). Although the number of Th17 cells was significantly lower in the iRA group compared with that in the aRA group, Th17 percentages in the iRA group were remained significantly high compared with the NCs (P<0.0001).
It has been reported that Tregs can inhibit Th17 activity, and a skewed Th17/Treg balance may be a characteristic feature of chronic inflammatory diseases such as RA (21) Fig. 2C ).
Taken together, these data reveal that ICOS + Tregs and Th17 were increased in patients with RA; however, their respective increases differed depending on the status of the disease. This suggests that imbalances between ICOS + Tregs and Th17 may contribute to disease progression and remission.
Anti-inflammatory cytokines increase in RA, particularly iRA, whereas pro-inflammatory cytokine IL-17 increases in aRA.
Cytokines produced by various synovial cell populations serve significant roles in the pathogenesis of RA (26) . To further examine whether cytokine profiles of ICOS + Tregs were dysregulated in patients RA, T cells were stimulated with PMA and ionomycin for 5 h in the presence of BFA, followed by intracellular staining to detect IL-10, TGF-β, IL-35 (anti-inflammatory cytokines) and IL-17 (a pro-inflammatory cytokine). As demonstrated in Fig. 3A and B, ICOS + Tregs from the iRA group contained twice the number of IL-10-producing cells than those from the aRA group (9.75±1.32% vs. 4.09±0.32%; P<0.005) and 5 times more IL-10-producing cells compared with those from the NCs (1.90±0.59%; P<0.0005). The percentages of IL-10-producing ICOS + Tregs from patients with aRA were higher compared with those in NCs (P<0.005).
Similarly, the percentages of TGF-β-producing ICOS + Tregs were increased in patients with iRA in comparison with patients with aRA (13.25±0.89% vs. 5.52±0.43%; P<0.0001) and the NCs (7.58±1.93%; P<0.05; Fig. 3C and D) . However, no significant differences in TGF-β-producing ICOS + Tregs were identified between the aRA group and the NCs.
IL-35, which serves a role in immune suppression of murine Treg, is a dimeric protein composed of IL-12α and IL-27β chains that is encoded by IL12A and EBI3 genes, respectively (27) . IL-35 producing ICOS + Tregs were detected from fresh PBMCs after 5 h of PMA and ionomycin stimulation. However, as Fig. 3G and H) . No significant differences in the percentage of IL-17-producing ICOS + Tregs were identified between the iRA and NC groups.
Together, these data reveal that the aRA group had Fig. 4B ). TGF-β-producing cells in ICOS + Tregs were increased in the iRA group (23.96±1.08) compared with that in the aRA (7.54±0.80; P<0.0001) and NC groups (9.21±1.10; P<0.0001; Fig. 4C ). Although the number of IL-10-producing cells in ICOS + Tregs from the iRA group was higher compared with that of the NCs, the two groups had similar numbers of TGF-β-producing cells. In comparison with suppressive cytokine expression, the number of IL-17-producing cells in ICOS + Tregs was highest in the aRA group, and no significant difference was identified between the iRA and NC groups (Fig. 4C) . Thus, the differences in ICOS + Tregs observed in freshly isolated PBMCs from the three groups remained virtually unchanged following in vitro TCR and IL-2 stimulation.
Discussion
It has been reported that Th17 cells promote autoimmunity and inflammation, and diseases associated with these conditions such as RA (8), whereas Tregs are involved in maintaining immune responses and preventing autoimmunity (11, 28) . The balance between activated responder T cells and Tregs may influence the extent of immunoregulation in RA (29) . Additionally, humans and mice contain ICOS + and ICOS -Tregs, which exhibit different properties. The current study demonstrated the amount of ICOS + Tregs increased in a cohort of Chinese patients with RA. The increase in ICOS + Tregs was larger in patients with iRA compared with those in patients with aRA, and the frequencies of ICOS + Tregs in patients with RA were negatively correlated with DAS28 scores. It was reported that IL-17, TGF-β and IL-6 levels detected by ELISA were increased in peripheral blood serum of patients with RA (30) . Although the serum or plasma cytokines may reflect the status of disease in a patient, since several types of cells can secrete the total peripheral suppressive cytokines, the current study focused only on the cytokines produced 
